Schizophrenia | Schizoaffective Disorder
Item
structured clinical interview for dsm-iii-r diagnosis of schizophrenia or schizoaffective disorder
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
Positive and negative syndrome scale Factor Analysis
Item
panss 3 factor negative symptom inclusion score greater than 20 prior to study entry
boolean
C0451383 (UMLS CUI [1,1])
C0085801 (UMLS CUI [1,2])
Positive and negative syndrome scale
Item
panss total score between 60 and 110
boolean
C0451383 (UMLS CUI [1])
Rating scale Parkinsonism
Item
simpson-angus scale total score of 12 or less
boolean
C0681889 (UMLS CUI [1,1])
C0242422 (UMLS CUI [1,2])
Depression score | Suicide score
Item
calgary depression inventory total score of 10 and suicide score less than 2
boolean
C3483981 (UMLS CUI [1])
C0560334 (UMLS CUI [2])
Clinical Global Impression Questionnaire unchanged
Item
no change in clinical global impressions (cgi) scale score prior to study entry
boolean
C3639708 (UMLS CUI [1,1])
C0442739 (UMLS CUI [1,2])
Chlorpromazine equivalent Dosage
Item
chlorpromazine (cpz) equivalent of 1500 or less
boolean
C0008286 (UMLS CUI [1,1])
C3242703 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Sexually active Contraceptive methods
Item
willing to use an effective form of birth control throughout the study if sexually active
boolean
C0241028 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Extrapyramidal symptoms High
Item
high extrapyramidal symptom (eps) levels
boolean
C0234133 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
Psychotropic Drugs Started | Psychotropic Drugs Discontinued | Psychotropic Drugs Adjusted
Item
began, discontinued, or adjusted psychotropic medication within 2 weeks of study entry
boolean
C0033978 (UMLS CUI [1,1])
C1272689 (UMLS CUI [1,2])
C0033978 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0033978 (UMLS CUI [3,1])
C0456081 (UMLS CUI [3,2])
Investigational New Drugs
Item
taking investigational medication within 2 weeks of study entry
boolean
C0013230 (UMLS CUI [1])
Medical contraindication Investigational New Drugs
Item
contraindication to study medication
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Illness Serious | Illness Unstable
Item
serious or unstable medical illness
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Substance Use Disorders
Item
alcohol or drug abuse within 6 months of study entry
boolean
C0038586 (UMLS CUI [1])
Neurodegenerative Disorders | Epilepsy
Item
diagnosed with neurodegenerative disease or a seizure disorder
boolean
C0524851 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
Renal Insufficiency
Item
history of a kidney impairment
boolean
C1565489 (UMLS CUI [1])
Clozapine
Item
currently taking clozapine
boolean
C0009079 (UMLS CUI [1])
Antipsychotic Agents Quantity
Item
currently taking more than two antipsychotic medications
boolean
C0040615 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Stimulant | Cholinesterase Inhibitors
Item
currently taking stimulants or cholinesterase inhibitors
boolean
C0304402 (UMLS CUI [1])
C0008425 (UMLS CUI [2])